Covidien (COV) in Focus: Stock Falls 7% – Tale of the Tape

ZacksCovidien plc (COV) saw a big move last session, as the company’s shares fell by 7% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading below the volatile price range of $86.51 to $94.64 in the past one-month time frame.

The medical products company has seen a mixed track record when it comes to current year estimate revisions over the past few weeks (1 increase, 1 decrease), and the consensus for earnings hasn’t been in a trend either. This recent price action is discouraging, so make sure to keep a close watch on this firm in the near future, and especially on earnings estimates following the recent slump.

COV currently has a Zacks Rank #4 (Sell) while its Earnings ESP is positive.

Some better-ranked stocks in the same industry include ZELTIQ Aesthetics, Inc. (ZLTQ), Abaxis, Inc. (ABAX) and Alere Inc. (ALR). While ZELTIQ Aesthetics carries a Zacks Rank #1 (Strong Buy), Abaxis and Alere hold a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

To read this article on Zacks.com click here.

Be the first to comment

Leave a Reply